XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells

Abstract To further understand the role of XIAP in acute myeloid leukemia (AML), we suppressed XIAP expression by antisense oligonucleotides and determined the effect on gene expression profiles and biological pathways. XIAP inhibition upregulated expression of proteasome genes in a manner similar t...

Full description

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 37; no. 8; pp. 974 - 979
Main Authors Carter, Bing Z, Mak, Duncan H, Wang, Zhiqiang, Ma, Wencai, Mak, Po Yee, Andreeff, Michael, Davis, R. Eric
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract To further understand the role of XIAP in acute myeloid leukemia (AML), we suppressed XIAP expression by antisense oligonucleotides and determined the effect on gene expression profiles and biological pathways. XIAP inhibition upregulated expression of proteasome genes in a manner similar to the proteasome inhibitor bortezomib or MG132; decreased 20S proteasome activity, an effect which was diminished in the presence of a pan-caspase inhibitor; and increased IκBα, Mcl-1, and HSP70 in AML cells. In addition to multiple functions already described, XIAP contributes to increased proteasome activity in AML cells, and the antitumor effect of XIAP inhibition may be mediated in part through caspase-dependent proteasome inhibition.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2013.04.018